NGBiLab S3.E11: Vasomune Therapeutics

Vasomune Therapeutics is a clinical stage biotech company that spun out of Sunnybrook Research Institute in Toronto. Their lead molecule targets vascular leak, a common underlying factor in some of the most serious conditions in medicine including sepsis, pneumonia, cerebral edema, and severe burns.In this episode, Jim Wilson speaks with the President and CEO if Vasomune, Brian Jahns, about a company that has made remarkable progress to date and secures nearly $10million USD in non-dilutive funding. Brian makes a passionate case for Canadian self-reliance in life sciences... and asks Jim to share how the NGBi podcasts started.